Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with

Kenichi Fujii1, Stéphane G Carlier, Gary S Mintz

  • 1Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA.

Insights

Plaque rupture detected by intravascular ultrasound during coronary stenting is linked to higher creatine kinase-MB (CK-MB) release and increased risks of major adverse cardiac events within one year. This finding highlights the clinical significance of plaque rupture in acute coronary syndrome patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarkers

Background:

  • Patients undergoing coronary stent implantation, particularly those with acute coronary syndrome, face elevated risks of periprocedural and long-term adverse events.
  • Intravascular ultrasound (IVUS) can identify plaque rupture, a potential factor influencing outcomes after stenting.

Purpose of the Study:

  • To investigate the impact of IVUS-detected plaque rupture on creatine kinase-MB (CK-MB) isoenzyme release and 1-year clinical outcomes in patients receiving coronary stents.
  • To compare outcomes between patients with and without IVUS-identified plaque rupture.

Main Methods:

  • A comparative study involving 62 patients with IVUS-detected plaque rupture and 62 matched controls who underwent coronary stenting.
  • Assessment of periprocedural CK-MB isoenzyme release and 1-year composite rates of target lesion revascularization, myocardial infarction, and cardiac death.
  • Analysis included patients presenting with acute coronary syndrome.

Main Results:

  • Patients with plaque rupture showed significantly higher rates of CK-MB elevation compared to controls (35% vs. 10% for 1-3x ULN, p<0.001; 15% vs. 2% for >3x ULN, p=0.02).
  • Independent predictors of CK-MB elevation included plaque rupture (p=0.03) and unstable angina (p=0.04).
  • The plaque rupture group experienced higher composite rates of late adverse events (25% vs. 9%, p=0.03).

Conclusions:

  • IVUS-detected plaque rupture is associated with increased periprocedural CK-MB release following coronary stenting.
  • Plaque rupture independently predicts worse 1-year clinical outcomes in patients treated with coronary stents, including those with acute coronary syndrome.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...